Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in Germany

NCT00697320 · clinicaltrials.gov ↗

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Congenital Bleeding Disorder
Congenital FVII Deficiency
Glanzmann's Disease
Acquired Bleeding Disorder
Acquired Haemophilia

Interventions

DRUG: eptacog alfa (activated)

Sponsor

Novo Nordisk A/S